Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Stopped early · Phase 3
Conditions studied: Constipation-Predominant Irritable Bowel Syndrome
In brief
The main purpose of this study is to evaluate the long-term safety and tolerability of renzapride at a dose of 4 mg taken once daily for 12 months in women with constipation-predominant irritable bowel syndrome (IBS-C).
Key facts
- Study ID
- NCT00607971
- Run by
- Alizyme
- People needed
- 939
- Starts
- 2006-04-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2008-07-08
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- completed 12 weeks treatment in the preceding pivotal study ATL1251/038/CL
You may not qualify if…
- Subjects who are pregnant or breastfeeding
Where it is running
- Research Site — Chandler, Arizona, United States
- Research Site — Phoenix, Arizona, United States
- Research Site — Sierra Vista, Arizona, United States
- Research Site — Little Rock, Arkansas, United States
- Research Site — North Little Rock, Arkansas, United States
- Research Site — Anaheim, California, United States
- Research Site — Beverly Hills, California, United States
- Research Site — Burbank, California, United States
- Research Site — Carmichael, California, United States
- Research Site — Cerritos, California, United States
- Research Site — Chula Vista, California, United States
- Research Site — Cypress, California, United States
- Research Site — Laguna Hills, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — Orange, California, United States
- Research Site — Orange, California, United States
- Research Site — San Carlos, California, United States
- Research Site — San Diego, California, United States
- Research Site — San Diego, California, United States
- Research Site — San Francisco, California, United States
- Research Site — Colorado Springs, Colorado, United States
- Research Site — Lakewood, Colorado, United States
- Research Site — Littleton, Colorado, United States
- Research Site — Bristol, Connecticut, United States
- Research Site — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.